Enter assignee name

EPO Patents = 4

Trademarks = 2

Forward Citations = 3

Loading Chart...

15 inventors (with patents filed for the assignee):

Ji-Wang Chern (6 out of 15 patents)

Pei-Teh Chang (4 out of 5 patents)

Chao-Wu Yu (3 out of 3 patents)

4. Hardy W Chan (1 out of 5 patents)

5. Chen-Wei Huang (1 out of 4 patents)

6. Rahul Subhash Talekar (1 out of 1 patent)

7. Shin-Yu Lai (1 out of 1 patent)

8. Ajit Dhananjay Jagtap (1 out of 1 patent)

9. Hsiao-Chun Wang (1 out of 1 patent)

10. Grace Shiahuy Chen (1 out of 2 patents)

11. Jia-Rong Liu (1 out of 1 patent)

12. Yi-Hsun Ho (1 out of 1 patent)

13. Chan-Hui Huang (1 out of 1 patent)

14. Chia-Yu Wu (1 out of 1 patent)

15. Pei-Yun Hung (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 11535598 - Histone deacetylases (HDACs) inhibitors (2022-12-27),

2. 11413256 - Method for treating a neurodegenerative disorder (2022-08-16),

3. 9387209 - Histone deacetylases (HDACs) inhibitors (2016-07-12),

4. 9302992 - Multifunctional quinoline derivatives as anti-neurodegenerative agents (2016-04-05),

5. 9155739 - Histone deacetylases (HDACs) inhibitors (2015-10-13),

6. 8969361 - Cyclopropanecarboxylate esters of purine analogues (2015-03-03),

7. 8946282 - Indolin-2-one derivatives as protein kinase inhibitors (2015-02-03),

Annji Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the research, development, and production of innovative medications. With a strong focus on quality and innovation, Annji Pharmaceutical is committed to improving healthcare outcomes for patients worldwide. Established in 2005, Annji Pharmaceutical has grown rapidly to become a trusted name in the pharmaceutical industry, with a diverse portfolio of products that address a wide range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#612 in Taipei

#1,778 in Taiwan

Taipei, Taiwan

Annji Pharmaceutical Co., Ltd.